# US 12,005,206 B2 · Drug-coated balloon catheters for body lumens > Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt - Number: US 12,005,206 B2 - Document ID: US12005206B2 - Status: Granted - Kind: B2 - Application number: 17/255,701 - Filed: 2020-02-21 - Published: 2021-11-25 - Granted: 2024-06-11 - Earliest claimed: 2019-02-22 - Assignees: Urotronic, Inc. - Applicants: Urotronic, Inc. - Inventors: Lixiao Wang; Peter Barnett; David Hendrickson - Web page: https://patentgrep.com/patent/US12005206B2 ## CPC - A61M 25/10: Balloon catheters ({A61M25/0125 takes precedence; embolectomy A61B17/22032; retractors A61B17/02;} inflatable balloons for placing stents or stent-grafts A61F2/958 {; stomach balloons for treatment of obesity A61F5/0003; oesophagal tubes A61J15/00}) - A61K 31/337: having four-membered rings, e.g. taxol - A61K 31/436: the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin - A61L 29/16: Biologically active materials, e.g. therapeutic substances {(A61L29/048 takes precedence)} - A61P 31/00: Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics - A61L 2300/416: Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus - A61M 2025/105: {having a balloon suitable for drug delivery, e.g. by using holes for delivery, drug coating or membranes} - A61M 2025/1059: {having different inflatable sections mainly depending on the response to the inflation pressure, e.g. due to different material properties} - A61M 2025/1068: {having means for varying the length or diameter of the deployed balloon, this variations could be caused by excess pressure} - A61M 2210/105: Oesophagus - A61M 2210/1057: Duodenum - A61M 2210/106: Small intestine - A61M 2210/1064: Large intestine - A61M 2210/1085: Bladder - A61M 2210/1089: Urethra - A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)} - A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D) - A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K) - A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS ## Abstract A balloon catheter for treating, preventing, or reducing the recurrence of a stricture and/or cancer, or for treating benign prostatic hyperplasia (BPH), in a non-vascular body lumen; the balloon catheter comprising: An elongated balloon; a coating layer overlying an exterior surface of the balloon wherein the coating layer includes one or more water-soluble additives and an initial drug load of a therapeutic agent; and a length-control mechanism (600) which stretches and elongates the balloon during deflation, giving the balloon a smaller cross-sectional deflated profile for tracking through the body lumen and for removal after treatment. ## Claims ### Claim 1 A method for treatment of or reduction of the occurrence of an anastomotic stricture, the method comprising: providing a balloon catheter in a target site in a body lumen comprising the anastomotic stricture, wherein the anastomotic stricture comprises a stricture in an anastomosis between two portions of the same body structure, or between two different body structures, wherein the balloon catheter comprises an elongated balloon, and a coating layer overlying an exterior surface of the balloon, wherein the coating layer comprises an initial drug load of a therapeutic agent chosen from paclitaxel, docetaxel, taxol, rapamycin, sirolimus, zotarolimus, everolimus, tacrolimus, mTOR inhibitors, analogues thereof, and combinations thereof; inflating the balloon at the target site to contact the coating layer with walls of the body lumen at the location of the anastomotic stricture until the balloon achieves an inflated balloon diameter for an inflation period; deflating the balloon after the inflation period; and withdrawing the balloon catheter from the body lumen; wherein the balloon catheter provided in the target site is a soaked balloon catheter, wherein the balloon catheter is soaked outside the body with a soaking solution comprising water or saline, or the balloon catheter is soaked in the target site with a flushing solution comprising water or saline, or a combination thereof. ### Claim 2 (depends on 1) The method of claim 1, wherein the anastomotic stricture is an anastomotic non-vascular stricture. ### Claim 3 (depends on 1) The method of claim 1, wherein the body structure or two different body structures comprise an esophagus, stomach, small intestine, duodenum, jejunum, ileum, colon, rectum, large intestine, colon, rectum, urethra, ureter, or bladder neck. ### Claim 4 (depends on 1) The method of claim 1, wherein the anastomotic stricture comprises an esophageal stricture, stomach stricture, small intestine stricture, duodenum stricture, jejunum stricture, ileum stricture, colon stricture, rectum stricture, large intestine stricture, colorectal stricture, a stricture after gastric bypass, ileocolonic stricture, gastrointestinal stricture, urethral stricture, ureteral stricture, J-pouch stricture, or a bladder neck stricture. ### Claim 5 (depends on 1) The method of claim 1, wherein the anastomotic stricture is a fibrotic stricture. ### Claim 6 (depends on 1) The method of claim 1, further comprising performing forming the surgical anastomosis at the target site prior to the insertion of the balloon catheter into the target site. ### Claim 7 (depends on 1) The method of claim 1, wherein an anastomotic stricture is present at the target site, further comprising performing a stricturotomy at the target site prior to the insertion of the balloon catheter into the target site. ### Claim 8 (depends on 7) The method of claim 7, wherein the stricturotomy comprises needle knife electroincision, episiotomy, urethrotomy, direct vision internal urethrotomy (DVIU), endoscopic mucosal resection (EMR), or endoscopic sub-mucosal dissection (ESD). ### Claim 9 (depends on 1) The method of claim 1, wherein the balloon catheter comprises a length-control mechanism that stretches and elongates the balloon while the balloon is in a deflated state. ### Claim 10 (depends on 9) The method of claim 9, wherein the length-control mechanism stores energy during inflation of the balloon and wherein the stored energy is used to elongate the balloon once the balloon is in a deflated state. ### Claim 11 (depends on 9) The method of claim 9, wherein the energy for the length control mechanism is stored in the catheter shaft during the inflation of the balloon. ### Claim 12 (depends on 9) The method of claim 9, wherein the balloon catheter comprises an elongated rigid component from a distal end of the elongated balloon to at least a proximal end of the elongated balloon. ### Claim 13 (depends on 12) The method of claim 12, wherein the elongated rigid component is disposed inside or outside of a reinforcement tube that is continuous or discontinuous along a length of the elongated rigid component. ### Claim 14 (depends on 12) The method of claim 12, wherein a distal end of the elongated rigid component is mechanically coupled to a distal end of the elongated balloon, such that as the balloon is inflated force is transferred in a proximal direction along the elongated rigid component. ### Claim 15 (depends on 12) The method of claim 12, wherein a distal end of the elongated rigid component is attached to a distal end of the elongated balloon, or wherein the distal end of the elongated rigid component is attached to a catheter tip. ### Claim 16 (depends on 12) The method of claim 12, wherein the balloon catheter comprises a catheter shaft, wherein the proximal end of the elongated rigid component is attached to the catheter shaft at a proximal end of the elongated balloon or proximal to the proximal end of the elongated balloon. ### Claim 17 (depends on 12) The method of claim 12, wherein the balloon catheter comprises an elastic member attached to a proximal end of the elongated rigid component, such that as the elongated rigid component moves in a proximal direction force is stored in the elastic member, and such that as force is released from the elastic member force is applied from the elastic member to the elongated rigid component in a distal direction. ### Claim 18 (depends on 1) The method of claim 1, wherein the water-soluble additive is chosen from N-acetylglucosamine, N-octyl-D-gluconamide, N-nonanoyl-N-methylglycamine, N-octanoyl-N-methyl glutamine, C6-ceramide, dihydro-C6-ceramide, cerabroside, sphingomyelin, galaclocerebrosides, lactocerebrosides, N-acetyl-D-sphingosine, N-hexanoyl-D-sphingosine, N-octonoyl-D-sphingosine, N-lauroyl-D-sphingosine, N-palmitoyl-D-sphingosine, N-oleoyl-D-sphingosine, PEG caprylic/capric diglycerides, PEG8 caprylic/capric glycerides, PEG caprylate, PEG8 caprylate, PEG caprate, PEG caproate, glyceryl monocaprylate, glyceryl monocaprate, glyceryl monocaproate, monolaurin, monocaprin, monocaprylin, monomyristin, monopalmitolein, monoolein, creatine, creatinine, agmatine, citrulline, guanidine, sucralose, aspartame, hypoxanthine, theobromine, theophylline, adenine, uracil, uridine, guanine, thymine, thymidine, xanthine, xanthosine, xanthosine monophosphate, caffeine, allantoin, (2-hydroxyethyl)urea, N,N′-bis(hydroxymethyl)urea, pentaerythritol ethoxylate, pentaerythritol propoxylate, pentaerythritol propoxylate/ethoxylate, glycerol ethoxylate, glycerol propoxylate, trimethylolpropane ethoxylate, pentaerythritol, dipentaerythritol, crown ether, 18-crown-6, 15-crown-5, 12-crown-4, and combinations thereof. ### Claim 19 (depends on 1) The method of claim 1, wherein the water-soluble additive is chosen from pentaerythritol ethoxylate, pentaerythritol propoxylate, and combinations thereof. ### Claim 20 (depends on 1) The method of claim 1, wherein the balloon catheter is soaked in the target site with the flushing solution comprising water or saline. ### Claim 21 (depends on 20) The method of claim 20, wherein the balloon catheter is soaked outside the body with the soaking solution comprising water or saline. ### Claim 22 (depends on 1) The method of claim 1, wherein the balloon catheter comprises an elongated balloon having a main diameter, the elongated balloon comprising at least one neck section, the balloon comprising a first main section and a second main section on opposite sides of the neck section. ### Claim 23 (depends on 22) The method of claim 22, wherein the at least one neck section comprises an inflated diameter that is smaller than the main diameter when the balloon is inflated, during the inflating the inflated diameter of the neck section is the smallest diameter of the balloon catheter between the first main section and the second main section, during the inflating the inflated diameter of the neck section is greater than a diameter of the neck section prior to the inflation, and the at least one neck section comprises an area of reduced compliance during inflation relative to the first main section and the second main section. ### Claim 24 (depends on 22) The method of claim 22, wherein the inflating comprises inflating the first section, the second section, and the neck section of the balloon simultaneously via a single inflation lumen. ### Claim 25 (depends on 22) The method of claim 22, wherein the at least one neck section comprises a reinforcing material around a circumference of the neck section to reduce compliance of the neck section during the inflation, wherein the reinforcing material comprising a suture, monofilament, or multifilament, wherein the reinforcing material comprises nylon, a polyamide, an aromatic polyamide, ultra high molecular weight polyethylene (UHMWPE), a polyester, an aromatic polyester, polyethylene terephthalate (PET), or a combination thereof. ### Claim 26 (depends on 1) The method of claim 1, wherein inserting the balloon catheter into the target site in the body lumen comprises inserting the balloon catheter and a scope into the target site in the body lumen. ### Claim 27 (depends on 26) The method of claim 26, wherein the balloon catheter and the scope are positioned side-by-side or the balloon catheter is loaded into the scope. ### Claim 28 A method for treatment of or reduction of the occurrence of an anastomotic non-vascular stricture, the method comprising: inserting a balloon catheter into a target site in a body lumen comprising the anastomotic non-vascular stricture, wherein the anastomotic non-vascular stricture comprises a stricture in an anastomosis between two portions of the same body structure, or between two different body structures, wherein the balloon catheter comprises an elongated balloon, and a coating layer overlying an exterior surface of the balloon, wherein the coating layer comprises an initial drug load of a therapeutic agent; inflating the balloon at the target site to contact the coating layer with walls of the body lumen at the location of the anastomotic non-vascular stricture until the balloon achieves an inflated balloon diameter for an inflation period; deflating the balloon after the inflation period; and withdrawing the balloon catheter from the body lumen; wherein the balloon catheter provided in the target site is a soaked balloon catheter, wherein the balloon catheter is soaked outside the body with a soaking solution comprising water or saline, or the balloon catheter is soaked in the target site with a flushing solution comprising water or saline, or a combination thereof; and wherein the anastomotic non-vascular stricture comprises an esophageal stricture, stomach stricture, small intestine stricture, duodenum stricture, jejunum stricture, ileum stricture, colon stricture, rectum stricture, large intestine stricture, colorectal stricture, a stricture after gastric bypass, ileocolonic stricture, gastrointestinal stricture, urethral stricture, ureteral stricture, J-pouch stricture, or a bladder neck stricture, or the body structure or two different body structures comprise an esophagus, stomach, small intestine, duodenum, jejunum, ileum, colon, rectum, large intestine, colon, rectum, urethra, ureter, or bladder neck, or a combination thereof. ### Claim 29 A method for treatment of or reduction of the occurrence of an anastomotic non-vascular stricture, the method comprising: inserting a balloon catheter into a target site in a body lumen comprising the anastomotic non-vascular stricture, wherein the anastomotic non-vascular stricture comprises a stricture in an anastomosis between two portions of the same body structure, or between two different body structures, wherein the balloon catheter comprises an elongated balloon, and a coating layer overlying an exterior surface of the balloon, wherein the coating layer comprises an initial drug load of a therapeutic agent chosen from paclitaxel, docetaxel, taxol, rapamycin, sirolimus, zotarolimus, everolimus, tacrolimus, mTOR inhibitors, analogues thereof, and combinations thereof; inflating the balloon at the target site to contact the coating layer with walls of the body lumen at the location of the anastomotic non-vascular stricture until the balloon achieves an inflated balloon diameter for an inflation period; deflating the balloon after the inflation period; and withdrawing the balloon catheter from the body lumen; wherein the balloon catheter provided in the target site is a soaked balloon catheter, wherein the balloon catheter is soaked outside the body with a soaking solution comprising water or saline, or the balloon catheter is soaked in the target site with a flushing solution comprising water or saline, or a combination thereof; and wherein the anastomotic non-vascular stricture comprises an esophageal stricture, stomach stricture, small intestine stricture, duodenum stricture, jejunum stricture, ileum stricture, colon stricture, rectum stricture, large intestine stricture, colorectal stricture, a stricture after gastric bypass, ileocolonic stricture, gastrointestinal stricture, urethral stricture, ureteral stricture, J-pouch stricture, or a bladder neck stricture, or the body structure or two different body structures comprise an esophagus, stomach, small intestine, duodenum, jejunum, ileum, colon, rectum, large intestine, colon, rectum, urethra, ureter, or bladder neck, or a combination thereof.